NGL Fine Chem Ltd

₹ 1,900 -1.79%
May 16 1:02 p.m.
nglfinechem.com BSE: 524774
About

Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It caters to various Indian and global companies with high quality and reliable products. [1]

Key Points

Product Portfolio
Presently, Veterinary APIs is the main product of the company which account for 89% of its revenues, followed by Veterinary Formulations (5%), Human APIs (2%), Intermediates (2%) & Others (2%). [1] The company has been able to increase its market share in the lower share of its portfolio which has increased to the levels of 50-60%. [2]

Website BSE
  • Market Cap ₹ 1,174 Cr.
  • Current Price ₹ 1,900
  • High / Low ₹ 3,789 / 1,608
  • Stock P/E 22.5
  • Book Value ₹ 334
  • Dividend Yield 0.09 %
  • ROCE 34.8 %
  • ROE 28.9 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 28.54% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.51%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
40.70 37.21 37.42 35.48 42.42 68.21 72.79 71.79 75.91 78.50 81.37 78.21
32.06 32.54 33.57 33.27 29.83 49.49 50.98 50.96 52.78 61.96 69.32 68.22
Operating Profit 8.64 4.67 3.85 2.21 12.59 18.72 21.81 20.83 23.13 16.54 12.05 9.99
OPM % 21.23% 12.55% 10.29% 6.23% 29.68% 27.44% 29.96% 29.02% 30.47% 21.07% 14.81% 12.77%
1.35 1.06 1.27 0.91 2.25 2.85 3.65 2.53 4.92 4.89 4.41 2.28
Interest 0.44 0.58 0.64 0.60 0.60 0.54 0.37 0.33 0.37 0.40 0.42 0.37
Depreciation 1.75 1.78 1.88 1.86 1.87 1.81 1.86 1.85 1.93 1.96 1.90 1.88
Profit before tax 7.80 3.37 2.60 0.66 12.37 19.22 23.23 21.18 25.75 19.07 14.14 10.02
Tax % 28.97% 11.87% 21.92% 78.79% 28.46% 23.00% 24.62% 32.44% 24.85% 25.64% 23.20% 21.56%
Net Profit 5.54 2.97 2.03 0.14 8.85 14.80 17.51 14.31 19.35 14.19 10.85 7.86
EPS in Rs 8.97 4.81 3.29 0.23 14.33 23.96 28.34 23.16 31.32 22.97 17.56 12.72
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
35 36 56 79 88 96 100 114 153 152 258 319
30 32 48 68 73 74 74 92 121 129 181 253
Operating Profit 5 4 8 11 15 22 25 22 32 23 77 66
OPM % 14% 11% 14% 14% 17% 23% 26% 19% 21% 15% 30% 21%
0 0 0 -1 2 0 1 3 4 1 9 13
Interest 1 1 1 2 2 2 1 2 3 3 2 2
Depreciation 1 1 2 2 3 3 3 5 6 7 7 8
Profit before tax 4 2 4 7 13 18 23 18 28 14 76 69
Tax % 37% 32% 35% 32% 35% 36% 35% 29% 27% 26% 27% 24%
Net Profit 2 1 3 5 8 11 15 13 20 11 55 52
EPS in Rs 3.92 1.70 4.71 7.33 13.48 18.45 24.10 20.38 32.58 17.16 89.79 84.57
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 5% 10% 2% 2%
Compounded Sales Growth
10 Years: 24%
5 Years: 26%
3 Years: 28%
TTM: 23%
Compounded Profit Growth
10 Years: 48%
5 Years: 29%
3 Years: 37%
TTM: -6%
Stock Price CAGR
10 Years: 70%
5 Years: 38%
3 Years: 66%
1 Year: 21%
Return on Equity
10 Years: 27%
5 Years: 28%
3 Years: 30%
Last Year: 29%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
3 3 3 3 3 3 3 3 3 3 3 3
Reserves 13 14 17 21 30 41 56 69 89 98 152 203
Borrowings 6 10 13 17 13 14 23 27 27 28 16 27
9 10 14 15 21 19 20 31 23 26 34 44
Total Liabilities 32 37 47 56 67 78 102 129 142 156 206 278
11 10 18 19 17 24 25 56 61 61 58 59
CWIP 1 5 0 0 1 2 16 3 0 0 1 6
Investments 2 2 0 0 2 3 6 6 9 14 33 32
19 21 30 37 46 49 55 63 73 80 115 180
Total Assets 32 37 47 56 67 78 102 129 142 156 206 278

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
4 1 -0 -0 8 8 10 22 9 20 27 13
-6 -4 -3 -4 -3 -10 -10 -21 -10 -19 -24 -13
1 3 4 3 -4 2 0 0 0 -1 -1 -1
Net Cash Flow -0 -0 1 -1 1 0 -0 1 -1 -0 2 -1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 112 115 100 110 107 123 110 89 79 63 53 74
Inventory Days 103 113 126 77 106 90 114 134 106 154 132 136
Days Payable 153 149 142 103 0 104 135 179 88 106 77 85
Cash Conversion Cycle 62 79 84 84 214 109 89 43 97 111 108 125
Working Capital Days 86 96 97 97 86 102 94 64 116 110 85 122
ROCE % 22% 11% 19% 24% 29% 37% 34% 22% 28% 15% 52% 35%

Shareholding Pattern

Numbers in percentages

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
65.45 73.83 73.83 73.81 73.81 73.81 73.81 73.81 73.81 73.81 73.81 73.81
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
34.55 26.17 26.16 26.19 26.19 26.19 26.19 26.19 26.19 26.19 26.19 26.18

Documents

Announcements

Annual reports

Credit ratings

Concalls